Infectious Diseases
Dr. Simran Kohli
Recent Articles
8 totalInfectious Disease
FDA Authorizes Nirmatrelvir-Ritonavir (Paxlovid) for COVID-19: 89% Hospitalization Reduction in EPIC-HR Trial
FDA authorizes nirmatrelvir-ritonavir (Paxlovid) for COVID-19: 89% hospitalization reduction in high-risk adults.
infectious disease
Long COVID Management Update 2025: New Insights for Primary Care Providers
2025 long COVID management update: key insights for primary care providers on addressing persistent symptoms and improving patient outcomes.
Infectious Disease
WHO's 2026 Guidelines: A Comprehensive Approach to Combatting Antimicrobial Resistance
Explore WHO's 2026 guidelines on antimicrobial resistance, focusing on surveillance, infection control, and research investment.
Medical Research
Improve Ovarian Cancer Detection with Personalized Risk Score
Enhance patient outcomes with a cost-effective tool that combines blood test results and age for accurate ovarian cancer detection in women over 50.
Digital Health
Automate 90% of Intake Workflows with AI
Discover how AI-powered automation can streamline post-acute care workflows, freeing staff to focus on patient care and reducing administrative burdens.
Medical Research
Plant-Based Diet Cuts Type 2 Diabetes Risk
Discover how a plant-based diet can lower type 2 diabetes risk while reducing greenhouse gas emissions, benefiting both human and planetary health.
Digital Health
Stay Ahead with Daily Digital Health Updates
Get the latest digital health news, trends, and insights to enhance patient care and stay informed about industry developments and innovations.
Medical Research
Reuse Patient Studies to Cut Drug Dev Costs
Discover how reusing existing patient preference studies can optimize resource allocation and streamline drug development processes, reducing costs and improving efficiency.